La Crosse Encephalitis Clinical Trials

• Safety, Tolerability and Immunogenicity of the Venezuelan Equine Encephalitis (VEE) Attenuated Live-Virus Vaccine
  ClinicalTrials.gov Identifier: NCT00109304 - Active, not recruiting
  Venezuelan Equine Encephalitis
  
• TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-Up to Study 209)
  ClinicalTrials.gov Identifier: NCT00161967 - Active, not recruiting
  Encephalitis, Tick-Borne
  
• Determining Long-Term Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine
  ClinicalTrials.gov Identifier: NCT00412516 - Active, not recruiting
  Encephalitis, Japanese B
  
• Valacyclovir for longterm therapy of Herpes simplex encephalitis
  ClinicalTrials.gov Identifier: NCT00031486 - Recruiting
  Encephalitis, Herpes Simplex
  
• A Pilot Study of the Use of Rituximab in the Treatment of Chronic Focal Encephalitis
  ClinicalTrials.gov Identifier: NCT00259805 - Not yet recruiting
  Chronic Focal Encephalitis; Rasmussen''s Encephalitis
  
• Live Attenuated Japanese Encephalitis (JE) Vaccine Coadministered With Measles Vaccine in Infants 9 Months of Age
  ClinicalTrials.gov Identifier: NCT00463684 - Recruiting
  Japanese Encephalitis
  
• Efficacy of Tacrolimus and i.v.-Immunoglobulins in Rasmussen Encephalitis
  ClinicalTrials.gov Identifier: NCT00545493 - Recruiting
  Rasmussen Encephalitis
  
• Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults
  ClinicalTrials.gov Identifier: NCT00118924 - Recruiting
  Tick-Borne Encephalitis
  
• Boosterability of Live Attenuated Japanese Encephalitis (JE) Vaccine in Children Who Have Previously Received Inactivated JE Vaccine
  ClinicalTrials.gov Identifier: NCT00463476 - Recruiting
  Japanese Encephalitis
  
• Treatment of Japanese Encephalitis
  ClinicalTrials.gov Identifier: NCT00216268 - Recruiting
  Japanese Encephalitis
  
• Determining Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine
  ClinicalTrials.gov Identifier: NCT00249769 - Completed
  Encephalitis, Japanese B
  
• Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4-3'delta30) in Healthy Adults
  ClinicalTrials.gov Identifier: NCT00094718 - Recruiting
  West Nile Fever Encephalitis
  
• Dose-Finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations with FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years.
  ClinicalTrials.gov Identifier: NCT00161772 - Completed
  Tick-Borne Encephalitis
  
• FSME IMMUN NEW Follow-Up to Study 208 in Volunteers Aged 16 to 66 Years
  ClinicalTrials.gov Identifier: NCT00161876 - Completed
  Encephalitis, Tick-Borne
  
• Safety Study in Volunteers From 16 to 65 Years of Age: FSME IMMUN NEW Vs. ENCEPUR
  ClinicalTrials.gov Identifier: NCT00161824 - Completed
  Encephalitis, Tick-Borne
  
• Dose-Finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations with FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years.
  ClinicalTrials.gov Identifier: NCT00161798 - Completed
  Tick-Borne Encephalitis
  
• FSME IMMUN NEW Follow-Up to Study 205 in Children Aged 6 to 16 Years
  ClinicalTrials.gov Identifier: NCT00161889 - Completed
  Encephalitis, Tick-Borne
  
• FSME IMMUN NEW Follow-Up to Study 199 in Children Aged 1 to 6 Years
  ClinicalTrials.gov Identifier: NCT00161850 - Completed
  Encephalitis, Tick-Borne
  
• Immunogenicity and Safety Study of a Rapid Immunization Schedule with FSME-IMMUN 0.5 mL in Healthy Adults Aged 16 - 65 Years
  ClinicalTrials.gov Identifier: NCT00161954 - Completed
  Encephalitis, Tick-Borne
  
• Immunogenicity and Safety Study of FSME-IMMUN 0.5 mL in Adult Subjects Previously Vaccinated According to a Rapid Immunization Schedule
  ClinicalTrials.gov Identifier: NCT00460486 - Active, not recruiting
  Encephalitis, Tick-Borne
  
• Natural History of West Nile Virus Infection
  ClinicalTrials.gov Identifier: NCT00069303 - Recruiting
  West Nile Virus; Encephalitis; Myelitis
  
• TBE Antibody Persistence and Booster Vaccination Study in Adults (Follow-up to Study 223)
  ClinicalTrials.gov Identifier: NCT00503529 - Active, not recruiting
  Encephalitis, Tick-Borne
  
• Safety and Immunogenicity Study of 3 Vaccinations With TICOVAC in 2 Dosages in Healthy Children Aged Between 6 Months and 3 Years
  ClinicalTrials.gov Identifier: NCT00161746 - Completed
  Encephalitis, Tick-Borne
  
• Structure of the Herpes Simplex Virus Receptor
  ClinicalTrials.gov Identifier: NCT00001648 - Recruiting
  Encephalitis; Herpes Simplex; Keratitis; Mouth Disease; Skin Disease
  
• Safety Study of ChimeriVax™-JE Vaccine to Prevent Japanese Encephalitis.
  ClinicalTrials.gov Identifier: NCT00314132 - Completed
  Encephalitis Virus, Vaccine
  
• Evaluation of Long-Term Immunogenicity in Children and Adolescents Boosted With a New Pediatric TBE Vaccine After Five Years
  ClinicalTrials.gov Identifier: NCT00452621 - Recruiting
  Encephalitis, Tick-Borne
  
• A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVaxTM-JE and JE-VAX
  ClinicalTrials.gov Identifier: NCT00314145 - Completed
  Japanese Encephalitis
  
• A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVaxTM-JE and JE-VAX
  ClinicalTrials.gov Identifier: NCT00319592 - Completed
  Japanese Encephalitis
  
• IVIG - West Nile encephalitis: Safety and Efficacy
  ClinicalTrials.gov Identifier: NCT00068055 - Active, not recruiting
  West Nile Fever
  
• Safety and Long-Term Evaluation (up to 5 Years) of First Booster Immunization With Novartis' TBE Vaccine for Adults in Adolescents and Adults
  ClinicalTrials.gov Identifier: NCT00387634 - Recruiting
  Tick Born Encephalitis
  
• Safety and Efficacy Study of ChimeriVax(TM)-JE and JE Inactivated Mouse Brain Vaccine in Children of Descending Age and Possible Interaction With Measles Vaccine
  ClinicalTrials.gov Identifier: NCT00441259 - Recruiting
  Japanese Encephalitis
  
• Safety Investigation of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years
  ClinicalTrials.gov Identifier: NCT00161863 - Completed
  Tick-Borne Encephalitis
  
• Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5ml in Adults Aged 18 - 67 Years
  ClinicalTrials.gov Identifier: NCT00161785 - Completed
  Tick-Borne Encephalitis
  
• Risperidone LA Study
  ClinicalTrials.gov Identifier: NCT00272597 - Recruiting
  Psychosis, Schizophrenia
  
• LA Health Project HIPTeens Project (a Secondary Prevention Program) and the Wise Mind Project (a Primary Prevention Program).
  ClinicalTrials.gov Identifier: NCT00289315 - Active, not recruiting
  Childhood Obesity
  
• Safety and Effectiveness of the Nit-Occlud® Lê VSD Spiral Coil System
  ClinicalTrials.gov Identifier: NCT00390702 - Recruiting
  Heart Septal Defects, Ventricular
  
• Pallidal Stimulation and Gilles de la Tourette Syndrome
  ClinicalTrials.gov Identifier: NCT00478842 - Not yet recruiting
  Gilles de la Tourette Syndrome
  
• National Gilles De La Tourette Study Group
  ClinicalTrials.gov Identifier: NCT00169351 - Recruiting
  Tourette Syndrome
  
• Detrol LA vs Estrace Vaginal Cream for the Treatment of Overactive Bladder Symptoms
  ClinicalTrials.gov Identifier: NCT00465894 - Recruiting
  Overactive Bladder; Postmenopausal
  
• Pharmacokinetic Study of a Single Dose of AVI-4065 in Cerebral Spinal Fluid
  ClinicalTrials.gov Identifier: NCT00381433 - Completed
  Encephalitis
  
• Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for Adults
  ClinicalTrials.gov Identifier: NCT00311493 - Completed
  Encephalitis, Tick-Borne
  
• Study of the Safety, Tolerability and Immune Response of TBE Vaccines Administered to Healthy Children.
  ClinicalTrials.gov Identifier: NCT00311441 - Completed
  Encephalitis, Tick-Borne
  
• Treatment of Cerebral Toxoplasmosis in HIV/AIDS
  ClinicalTrials.gov Identifier: NCT00367081 - Completed
  Toxoplasmic Encephalitis; AIDS
  
• Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children
  ClinicalTrials.gov Identifier: NCT00163618 - Completed
  Encephalitis, Tick-Borne
  
• Cohort of Children With Acute Immune or Idiopathic Thrombocytopenic Purpura (ITP) : a Prospective Study in Pays De La Loire
  ClinicalTrials.gov Identifier: NCT00331357 - Not yet recruiting
  Acute Idiopathic Thrombocytopenic Purpura
  
• Immunogenicity and Safety Study of a Third Vaccination With FSME-IMMUN 0.5 mL in Subjects Previously Vaccinated According to a Rapid Immunization Schedule (Follow-up to Study 225)
  ClinicalTrials.gov Identifier: NCT00163540 - Completed
  Encephalitis, Tick-Borne
  
• Toxoplasmic Encephalitis in Patients With AIDS. Treatment and Prevention of Relapse
  ClinicalTrials.gov Identifier: NCT00002064 - Completed
  Toxoplasmosis, Cerebral; HIV Infections
  
• A Pilot Study of 566C80 for the Salvage Treatment of Toxoplasmic Encephalitis in Patients Infected With the Human Immunodeficiency Virus (HIV) Who Have Failed or are Intolerant of Pyrimethamine-Sulfadiazine
  ClinicalTrials.gov Identifier: NCT00001994 - Completed
  Toxoplasmosis, Cerebral; HIV Infections
  
• A Randomized Prospective Study of Pyrimethamine Therapy for Prevention of Toxoplasmic Encephalitis in HIV-Infected Individuals With Serologic Evidence of Latent Toxoplasma gondii Infection
  ClinicalTrials.gov Identifier: NCT00000666 - Completed
  Toxoplasmosis, Cerebral; HIV Infections
  
• A Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS
  ClinicalTrials.gov Identifier: NCT00000674 - Completed
  Toxoplasmosis, Cerebral; HIV Infections
  
• Effect Of Detrol LA With Behavioral Intervention In Overactive Bladder Subjects Dissatisfied With Recent OAB Medication.
  ClinicalTrials.gov Identifier: NCT00230789 - Completed
  Urinary Incontinence
  
• Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis
  ClinicalTrials.gov Identifier: NCT00000794 - Completed
  Toxoplasmosis, Cerebral; HIV Infections
  
• Efficacy and Tolerability of DITROPAN® XL (Oxybutynin Chloride) Versus DETROL® LA (Tolterodine Tartrate) in Treatment of Overactive Bladder
  ClinicalTrials.gov Identifier: NCT00293839 - Completed
  Urinary Incontinence
  
• Effects Of Detrol LA On Memory And Cognition In Elderly Population
  ClinicalTrials.gov Identifier: NCT00411437 - Completed
  Memory; Cognition
  
• Detrol LA In Men With Overactive Bladder.
  ClinicalTrials.gov Identifier: NCT00282932 - Completed
  Overactive Bladder (OAB)
  
• Effect of Detrol LA on Overactive Bladder Symptoms, Sexual Quality of Life and Sexual Function in Women
  ClinicalTrials.gov Identifier: NCT00143481 - Completed
  Urinary Incontinence
  
• A Double-Blind Randomized, Placebo-Controlled, Crossover Study of Single Doses of OROS Methylphenidate Hydrochloride (CONCERTA) and Long-Acting Methylphenidate Hydrochloride (RITALIN LA) in Healthy Adults
  ClinicalTrials.gov Identifier: NCT00302354 - Completed
  Healthy Volunteers
  
• Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction
  ClinicalTrials.gov Identifier: NCT00147654 - Completed
  Urinary Incontinence